Artigos de revistas sobre o tema "Affordable medicines"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Affordable medicines".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Kuwonu, Franck. "Wanted: Affordable medicines for all". Africa Renewal 30, n.º 3 (13 de março de 2017): 17. http://dx.doi.org/10.18356/93d2f713-en.
Texto completo da fonteBate, Roger, e Kimberly Hess. "Affordable Medicines Facility for malaria". Lancet Infectious Diseases 9, n.º 7 (julho de 2009): 396–97. http://dx.doi.org/10.1016/s1473-3099(09)70158-6.
Texto completo da fonteHuz, V. S. "The study of the awareness and participation of pharmacists in the “Affordable Medicines” government program". Social Pharmacy in Health Care 9, n.º 3 (17 de novembro de 2023): 50–56. http://dx.doi.org/10.24959/sphhcj.23.296.
Texto completo da fontePearce, Alison, Kees van Gool, Philip Haywood e Marion Haas. "Delays in access to affordable medicines: putting policy into perspective". Australian Health Review 36, n.º 4 (2012): 412. http://dx.doi.org/10.1071/ah11110.
Texto completo da fonteTozan, Yesim, Albrecht Jahn e Olaf Müller. "Evaluation of the Affordable Medicines Facility—malaria". Lancet 381, n.º 9872 (março de 2013): 1095. http://dx.doi.org/10.1016/s0140-6736(13)60756-4.
Texto completo da fonteOzawa, Sachiko, Raja Shankar, Christine Leopold e Samuel Orubu. "Access to medicines through health systems in low- and middle-income countries". Health Policy and Planning 34, Supplement_3 (1 de dezembro de 2019): iii1—iii3. http://dx.doi.org/10.1093/heapol/czz119.
Texto completo da fonteKhanal, Saval, Lennert Veerman, Margaret Ewen, Lisa Nissen e Samantha Hollingworth. "Availability, Price, and Affordability of Essential Medicines to Manage Noncommunicable Diseases: A National Survey From Nepal". INQUIRY: The Journal of Health Care Organization, Provision, and Financing 56 (janeiro de 2019): 004695801988757. http://dx.doi.org/10.1177/0046958019887572.
Texto completo da fonteZhu, Yulei, Ying Wang, Xiaoluan Sun e Xin Li. "Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China". International Journal of Environmental Research and Public Health 16, n.º 19 (3 de outubro de 2019): 3728. http://dx.doi.org/10.3390/ijerph16193728.
Texto completo da fonteChen, Zhe, Siyu Li, Imti Choonara, Kun Zou, Linan Zeng, Liang Huang, Zhi-Jun Jia et al. "Access to medicines for children in China". BMJ Paediatrics Open 6, n.º 1 (dezembro de 2022): e001635. http://dx.doi.org/10.1136/bmjpo-2022-001635.
Texto completo da fonteChattu, Vijay Kumar, Bawa Singh, Sanjay Pattanshetty e Srikanth Reddy. "Access to medicines through global health diplomacy". Health Promotion Perspectives 13, n.º 1 (30 de abril de 2023): 40–46. http://dx.doi.org/10.34172/hpp.2023.05.
Texto completo da fonteWise, J. "Patent wars: affordable medicines versus intellectual property rights". BMJ 348, feb17 4 (17 de fevereiro de 2014): g1533. http://dx.doi.org/10.1136/bmj.g1533.
Texto completo da fonteKhan, Nazish. "‘Cutting-edge’ medicines vs. affordable quality health care?" British Journal of Cardiac Nursing 11, n.º 8 (2 de agosto de 2016): 370–71. http://dx.doi.org/10.12968/bjca.2016.11.8.370.
Texto completo da fonteThe Lancet. "Resistance to the Affordable Medicines Facility for malaria?" Lancet 373, n.º 9673 (abril de 2009): 1400. http://dx.doi.org/10.1016/s0140-6736(09)60798-4.
Texto completo da fonteKamal-Yanni, Mohga. "Affordable medicines facility for malaria: reasonable or rash?" Lancet 375, n.º 9709 (janeiro de 2010): 121. http://dx.doi.org/10.1016/s0140-6736(10)60048-7.
Texto completo da fonteArrow, Kenneth J., Patricia M. Danzon, Hellen Gelband, Dean Jamison, Ramanan Laxminarayan, Anne Mills, Germano Mwabu, Claire Panosian, Richard Peto e Nicholas J. White. "The Affordable Medicines Facility—malaria: killing it slowly". Lancet 380, n.º 9857 (dezembro de 2012): 1889–90. http://dx.doi.org/10.1016/s0140-6736(12)61843-1.
Texto completo da fonteLalani, Mirza, Scott Kaba Matafwali, Aminata Dior Ndiaye, Jayne Webster, Sian E. Clarke e Harparkash Kaur. "An absence of evidence breeds contempt: A qualitative study of health system stakeholder perceptions of the quality of medicines available in Senegal". PLOS Global Public Health 3, n.º 7 (12 de julho de 2023): e0002004. http://dx.doi.org/10.1371/journal.pgph.0002004.
Texto completo da fonteKucherenko, L. I., I. V. Nizhenkovska, N. V. Sholoiko, L. O. Hala e N. O. Datsiuk. "External reference pricing for medicines in Ukraine: latest trends". Current issues in pharmacy and medicine: science and practice 16, n.º 3 (3 de novembro de 2023): 272–76. http://dx.doi.org/10.14739/2409-2932.2023.3.287758.
Texto completo da fonteBlavatska, O. B., O. M. Zaliska, Ya O. Hrynkiv e H. O. Sosnovska. "Analysis of development dynamics of the program «Affordable medicines» in Ukraine and Lviv region". Farmatsevtychnyi zhurnal, n.º 2 (7 de maio de 2020): 3–11. http://dx.doi.org/10.32352/0367-3057.2.20.01.
Texto completo da fonteГончар, А. О., Н. В. Шолойко e О. О. Комаріда. "Reimbursement of combined antihypertensive medicenes in Ukraine: aspects of inclusion and external reference pricing". Farmatsevtychnyi zhurnal, n.º 6 (29 de dezembro de 2022): 53–59. http://dx.doi.org/10.32352/0367-3057.6.22.06.
Texto completo da fonteDixit, Avika, Neeta Kumar e Sanjiv Kumar. "Use of Generic Medicines". Journal of Health Management 20, n.º 1 (23 de janeiro de 2018): 84–90. http://dx.doi.org/10.1177/0972063417747747.
Texto completo da fonteShevchenko, M. V., T. P. Yurochko e O. S. Skrypnikova. "Adoption of the governmental affordable medicines programme by ukrainians." Medicni perspektivi (Medical perspectives) 25, n.º 2 (1 de julho de 2020): 37–43. http://dx.doi.org/10.26641/2307-0404.2020.2.206350.
Texto completo da fonteAdeyi, Olusoji, e Rifat Atun. "Innovating for impact: The Affordable Medicines Facility-malaria (AMFm)". Nature Medicine 15, n.º 9 (setembro de 2009): 991. http://dx.doi.org/10.1038/nm0909-991b.
Texto completo da fonteTougher, Sarah, Yazoume Ye, Catherine Goodman, Fred Arnold e Kara Hanson. "Evaluation of the Affordable Medicines Facility—malaria – Authors' reply". Lancet 381, n.º 9872 (março de 2013): 1095–96. http://dx.doi.org/10.1016/s0140-6736(13)60757-6.
Texto completo da fonteSaleh, Kamaruzaman, e Mohamed I. M. Ibrahim. "Are Essential Medicines in Malaysia Accessible, Affordable and Available?" Pharmacy World & Science 27, n.º 6 (dezembro de 2005): 442–46. http://dx.doi.org/10.1007/s11096-005-1318-8.
Texto completo da fonteSearles, Andrew, Evan Doran, Thomas A. Faunce e David Henry. "The affordability of prescription medicines in Australia: are copayments and safety net thresholds too high?" Australian Health Review 37, n.º 1 (2013): 32. http://dx.doi.org/10.1071/ah11153.
Texto completo da fonteMuriu, Daniel Wanjau. "Third World Resistance to International Economic and Structural Constraints: Assessing the Utility of the Right to Health in the Context of the TRIPS Agreement". International Community Law Review 11, n.º 4 (2009): 409–29. http://dx.doi.org/10.1163/187197409x12525781476169.
Texto completo da fonteCarradinha, Hugo. "Tendering Short-Term Pricing Policies and the Impact on Patients, Governments and the Sustainability of the Generic Medicines Industry". Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 6, n.º 4 (agosto de 2009): 351–61. http://dx.doi.org/10.1057/jgm.2009.29.
Texto completo da fonteSwain, Sujata, e Rajdeep Niyogi. "SmartMedicist: a context-aware system for recommending an alternative medicine". International Journal of Pervasive Computing and Communications 14, n.º 2 (4 de junho de 2018): 147–64. http://dx.doi.org/10.1108/ijpcc-d-18-00021.
Texto completo da fonteÖzler, Gökçen, e Oğuz Işik. "Prices, availability and affordability of selected essential medicines for chronic diseases in Türkiye". Eastern Mediterranean Health Journal 29, n.º 11 (30 de novembro de 2023): 850–60. http://dx.doi.org/10.26719/emhj.23.117.
Texto completo da fonteBissell, Karen, Philippa Ellwood, Eamon Ellwood, Chen-Yuan Chiang, Guy Marks, Asma El Sony, Innes Asher, Nils Billo e Christophe Perrin. "Essential Medicines at the National Level: The Global Asthma Network’s Essential Asthma Medicines Survey 2014". International Journal of Environmental Research and Public Health 16, n.º 4 (19 de fevereiro de 2019): 605. http://dx.doi.org/10.3390/ijerph16040605.
Texto completo da fonteSri Ranganathan, Shalini, Thiyahiny Sunil Navaratinaraja, Ramasamy Balasubramaniam e Hemantha Beneragama. "Price and affordability of key essential medicines for children in Sri Lanka, a lower-middle-income country: comparison of two national cross-sectional surveys done 8 years apart". BMJ Open 13, n.º 2 (fevereiro de 2023): e069733. http://dx.doi.org/10.1136/bmjopen-2022-069733.
Texto completo da fonteOrubu, Ebiowei S. F., Faith O. Robert, Mercy Samuel e Daniel Megbule. "Access to essential cardiovascular medicines for children: a pilot study of availability, price and affordability in Nigeria". Health Policy and Planning 34, Supplement_3 (1 de dezembro de 2019): iii20—iii26. http://dx.doi.org/10.1093/heapol/czz057.
Texto completo da fonteMarchetti, Federico, e Antonio Addis. "La riforma europea della legislazione farmaceutica". Medico e Bambino Pagine elettroniche 26, n.º 7 (30 de setembro de 2023): 113–18. http://dx.doi.org/10.53126/mebxxvis113.
Texto completo da fonteWidayati, Aris, Damiana Sapta Candrasari, Lusia Jois Mariana e Veronica Veronica. "PERCEPTIONS OF TRADITIONAL MEDICINES FOR SELF-MEDICATION AMONG PEOPLE IN DIENG PLATEAU CENTRAL JAVA PROVINCE, INDONESIA". Jurnal Riset Kesehatan 10, n.º 2 (2 de dezembro de 2021): 132–38. http://dx.doi.org/10.31983/jrk.v10i2.7692.
Texto completo da fonteHuz, V. S., e O. M. Zaliska. "Analysis of dynamics of the drug list in the аffordable medicines program for treatment of cardiovascular diseases". Farmatsevtychnyi zhurnal, n.º 3 (1 de julho de 2019): 21–30. http://dx.doi.org/10.32352/0367-3057.3.19.03.
Texto completo da fonteWonder, Michael, e Geoffrey Chin. "Delays in access to affordable medicines: putting policy into perspective". Australian Health Review 37, n.º 4 (2013): 430. http://dx.doi.org/10.1071/ah13037.
Texto completo da fonteGhinea, Narcyz, e Wendy Lipworth. "Affordable access to innovative cancer medicines — don't forget the prices". Medical Journal of Australia 204, n.º 6 (abril de 2016): 214–15. http://dx.doi.org/10.5694/mja15.01309.
Texto completo da fonteMartin, Jennifer H., Wayne Hall, Mary‐Ann Fitzcharles, Laura Borgelt e Jose Crippa. "Ensuring access to safe, effective, and affordable cannabis‐based medicines". British Journal of Clinical Pharmacology 86, n.º 4 (3 de março de 2020): 630–34. http://dx.doi.org/10.1111/bcp.14242.
Texto completo da fonteZaliska, O., V. Huz e N. Maksymovych. "PDG42 Reimbursement Program "Affordable Medicines” in Ukraine: Issues and Challenges". Value in Health 23 (dezembro de 2020): S526. http://dx.doi.org/10.1016/j.jval.2020.08.725.
Texto completo da fonteWang, Haipeng, Qiang Sun, Agnes Vitry e Tuan Anh Nguyen. "Availability, Price, and Affordability of Selected Essential Medicines for Chronic Diseases in 11 Countries of the Asia Pacific Region: A Secondary Analysis". Asia Pacific Journal of Public Health 29, n.º 4 (11 de abril de 2017): 268–77. http://dx.doi.org/10.1177/1010539517700472.
Texto completo da fonteOcheredko, O. M., e A. A. Rudenko. "Evaluation of the effectiveness of the gastroduodenitis prevention program in patients of retirement age with essential arterial hypertension who participated in the “Affordable Medicines” program according to the IECR". Reports of Vinnytsia National Medical University 26, n.º 2 (14 de junho de 2022): 286–91. http://dx.doi.org/10.31393/reports-vnmedical-2022-26(2)-19.
Texto completo da fonteNistor, Adina-Loredana, Elizabeth Pisani e Maarten Olivier Kok. "Why falsified medicines reach patients: an analysis of political and economic factors in Romania". BMJ Global Health 6, Suppl 3 (fevereiro de 2023): e009918. http://dx.doi.org/10.1136/bmjgh-2022-009918.
Texto completo da fonteKotwani, Anita. "Psychiatric medicines in India: why public healthcare facilities and a thriving generics industry cannot assure access and affordability". International Psychiatry 9, n.º 2 (maio de 2012): 34–36. http://dx.doi.org/10.1192/s1749367600003052.
Texto completo da fonteMustafa, Ayesha, e Anam Yasmeen. "ACCESS TO MEDICINE". International Journal of Pharmacy & Integrated Health Sciences 3, n.º 2 (24 de outubro de 2022): 118–21. http://dx.doi.org/10.56536/ijpihs.v3i2.34.
Texto completo da fonteCortez, Rafael, Andre Medici e Rucheta Singh. "Out-of-Pocket Spending and Financial Equity in the Access to Medicines in Latin America: Trends and Challenges: 2010-2020". Journal of Law, Medicine & Ethics 51, S1 (2023): 17–38. http://dx.doi.org/10.1017/jme.2023.136.
Texto completo da fonteSharma, Manish Kumar, e Rashmi Gupta. "Nanorobotics: The Future of Medicines". Research in Pharmacy and Health Sciences 2, n.º 1 (15 de fevereiro de 2016): 51–56. http://dx.doi.org/10.32463/rphs.2016.v02i01.10.
Texto completo da fonteMosihuzzaman, M., e M. Iqbal Choudhary. "Protocols on safety, efficacy, standardization, and documentation of herbal medicine (IUPAC Technical Report)". Pure and Applied Chemistry 80, n.º 10 (1 de janeiro de 2008): 2195–230. http://dx.doi.org/10.1351/pac200880102195.
Texto completo da fonteTadjimukhammadovna, Batirova Barchinoy. "AVAILABILITY AND COSTS OF MEDICINES FOR THE TREATMENT OF TUBERCULOSIS". International Journal of Medical Sciences And Clinical Research 4, n.º 1 (1 de janeiro de 2024): 60–64. http://dx.doi.org/10.37547/ijmscr/volume04issue01-11.
Texto completo da fonteНіженковська, І. В., М. М. Бабенко, Л. О. Гала, Н. В. Шолойко e Н. О. Дацюк. "Analysis of access to medicines for the population by the state budget in Ukraine". Farmatsevtychnyi zhurnal, n.º 5 (27 de outubro de 2023): 3–10. http://dx.doi.org/10.32352/0367-3057.5.23.01.
Texto completo da fonteZabadi, Achmad Fairuz, e Septiana Kurniasari. "Pattern of Drug Use in Influenza Self-Medication Efforts in Communities in Bettet Village, Pamekasan Regency". Journal Pharmasci (Journal of Pharmacy and Science) 7, n.º 2 (31 de julho de 2022): 65–69. http://dx.doi.org/10.53342/pharmasci.v7i2.282.
Texto completo da fonte